KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Characteristics and endoscopic ultrasound findings of gastrointestinal lesions: single-center experience
Aims: We aimed to present the characteristics, indications, endoscopic ultrasonography procedure details, diagnoses and complication rate of patients who underwent endosonpgraphy in a single center.
Methods: Forty six patients admitted to Trakya Unversity Faculty of Medicine and underwent EUS (±FNA) procedure between January 2021 and May 2022 were included in the study. Patients files were analysed retrospectively. Demographic characteristics, presence and types of comorbidity, presence and types of malignancy in the family, use of antithrombotic drugs, laboratory data, details of eus procedure, pathology results, adverse events were recorded. The data obtained in the study were analyzed using Statistical Package for Social Science for Windows 26 package program.
Results: A total of 46 patients were included in the study. 46% (n=21) were women. The median age was 64 (28-87). Antithrombotic use was present in 25% of the patients. Comorbidities were present in 84% of patients. The indications for EUS were predominantly pancreatic lesions (n=31). Aspirations were performed in addition to ultrasonographic examination in 78% (n=36) of the patients. 19 G (Gauge) needles were used in 30 and 25 G needles were used in 6 patients. Biopsy stations were stomach (n=31), duodenum (n=4), esophagus (n=1). Median long axis of the lesions was 34 (7-173) mm and the short axis was 26 (1-76) mm. 42% of the biopsied pancreatic lesions were cystic and 58% were solid. The CA19-9 level in solid lesions was statistically significantly higher than cystic (1512 /28 U/ml; p= 0.008). CA19-9 level was found mean 2061±3295 U/ml in patients with adenocarcinoma (n=8), 71±106 U/ml in cystic neoplasm and 152±338 in benign disorders (p=0.026). Cut-off value predicting adenocarsinoma with %87,5 spesifity and %87,5 sensitivity in our cohort was 174 U/ml (( AUC 0.85 ( 0.63-1)). Spesifity and sensitivity of the level 40 ( nearest level to universaly detected upper limit: 37 U/mL) was %62,5 and %87,5 respectively. Comparing malignant and benign lesions of pancreas overall, no statistical significance was found of CA19-9 level in predicting the diagnosis of tumor (p=0.15). Of the patients who underwent biopsy, 61% were malignant and 39% were benign. Malignant diagnoses were: adenocarsinoma, cystic neoplasm, gastrointestinal stromal tumor, neuroendocrine tumor, mesenchymal tumor, lumphoma, metastasis. Benign diagnoses were: otoimmune pancreatitis, normal cyst, chronic pancreatitis, pseudocyst, walled-off necrosis, polyp, no lesion. Post-procedure complications were not observed in any of the patients.
Conclusion: The availability of endoscopic ultrasonography is expanding nowadays. Endoscopy ultrasonography is a precise, advantageous, and risk-free technique when performed by trained personnel.


1. Strohm WD, Phillip J, Hagenmüller F, Classen M. Ultrasonic tomographyby means of an ultrasonic fiberendoscope. Endoscopy. 1980;12(5):241-244.doi:10.1055/s-2007-1021752
2. Vilmann P, Jacobsen GK, Henriksen FW, Hancke S. Endoscopicultrasonography with guided fine needle aspiration biopsy in pancreaticdisease. Gastrointest Endosc. 1992;38(2):172-173. doi:10.1016/s0016-5107(92)70385-x
3. Reddy Y, Willert RP. Endoscopic ultrasound: what is it and whenshould it be used? Clin Med (Lond). 2009;9(6):539-543. doi:10.7861/clinmedicine.9-6-539
4. Chung A, Kwan V. Endoscopic ultrasound: an overview of its role incurrent clinical practice. Australas J Ultrasound Med. 2009;12(2):21-29.doi:10.1002/j.2205-0140.2009.tb00050.x
5. Platt KD, Bhalla S, Sondhi AR, Millet JD, Law RJ. EUS-guidedgastrojejunostomy and hepaticogastrostomy for malignant duodenal andbiliary obstruction. VideoGIE. 2020;6(2):95-97. Published 2020 Dec 7.doi:10.1016/j.vgie.2020.10.013
6. Iglesias-Garcia J, Lariño-Noia J, de la Iglesia-García D, Dominguez-Muñoz JE. Endoscopic ultrasonography: Enhancing diagnostic accuracy.Best Pract Res Clin Gastroenterol. 2022;60-61:101808. doi:10.1016/j.bpg.2022.101808
7. Jenssen C, Alvarez-Sánchez MV, Napoléon B, Faiss S. Diagnosticendoscopic ultrasonography: assessment of safety and prevention ofcomplications. World J Gastroenterol. 2012;18(34):4659-4676. doi:10.3748/wjg.v18.i34.4659
8. Harras H, El-Kalla F, Elfert A, et al. Indications and outcomes ofendoscopic ultrasound in Tanta-Egypt: Initial experience. InternationalJournal of Cancer and Biomedical Research. 2021;5(1):123-132.
9. Baghbanian M, Baghbanian A, Salmanroghani H, Shabazkhani B. SerumCA19-9 in patients with solid pancreatic mass. Gastroenterol Hepatol BedBench. 2013;6(1):32-35.
10. Xing H, Wang J, Wang Y, et al. Diagnostic value of ca 19-9 andcarcinoembryonic antigen for pancreatic cancer: a meta-analysis.Gastroenterol Res Pract. 2018;2018:8704751. doi:10.1155/2018/8704751
11. Yamao K, Irisawa A, Inoue H, et al. Standard imaging techniques ofendoscopic ultrasound-guided fine-needle aspiration using a curvedlinear array echoendoscope. Digestive Endoscopy. 2007;19(s1):S180-S205.doi:https://doi.org/10.1111/j.1443-1661.2007.00742.x
12. Mizuide M, Ryozawa S, Fujita A, et al. Complications of endoscopicultrasound-guided fine needle aspiration: a narrative review. Diagnostics(Basel). 2020;10(11):964. Published 2020 Nov 17. doi:10.3390/diagnostics10110964
13. Wang KX, Ben QW, Jin ZD, et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. GastrointestEndosc. 2011;73(2):283-290. doi:10.1016/j.gie.2010.10.045
14. Siddiqui UD, Rossi F, Rosenthal LS, Padda MS, Murali-Dharan V,Aslanian HR. EUS-guided FNA of solid pancreatic masses: a prospective,randomized trial comparing 22-gauge and 25-gauge needles. GastrointestEndosc. 2009;70(6):1093-1097. doi:10.1016/j.gie.2009.05.037
15. Song TJ, Kim JH, Lee SS, et al. The prospective randomized, controlledtrial of endoscopic ultrasound-guided fine-needle aspiration using 22Gand 19G aspiration needles for solid pancreatic or peripancreatic masses.Am J Gastroenterol. 2010;105(8):1739-1745. doi:10.1038/ajg.2010.108
Volume 3, Issue 3, 2023
Page : 159-164
_Footer